Credit: Shutterstock photoBiotechnology stocks bolstered the broader healthcare sector last year, a theme that is expected to continue in 2018. Investors looking for a way to access potentially smaller biotechnology companies can consider the ALPS Medical Breakthroughs ETF (NYSEArca: SBIO), which focuses on small- and mid-cap companies that have one or more drugs in either Phase II [...] Read more on ETFtrends.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
This article was provided by our partner Tom Lydon of etftrends.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.